Due Diligence for Medical Products: An FDA Regulatory and Supply Chain Perspective
September 21, 2020
Arnold & Porter Webinar
In this webinar, our speakers highlight some of the most important FDA and supply chain-related due diligence considerations for parties to transactions in the life sciences sector, and provide practical advice on addressing critical issues necessary to avoid downstream complications and unanticipated liabilities.
Topics
- Issues related to developing investigational medical products
- FDA applications
- Compliance with FDA's Current Good Manufacturing Practice (CGMP) regulation
- Government enforcement actions
- Supply chain safety concerns
- Implications of President Trump's August 2020 "Buy American" executive order
- Role of foreign regulatory bodies